Latest Heska Corp (HSKA) Headlines This Company's

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Heska Corp (HSKA) Headlines

This Company's "Dismal" Performance Masks Excellent Opportunity
John Leonard, The Motley Fool - Motley Fool - Fri Feb 14, 1:30PM CST
Abaxis fell sharply after reporting disappointing results last month. However the recent recovery suggests the market is beginning to realize that the cause for the "dismal" results (the CEO's words)  is most likely a one-off occurrence rather...

Cambrex (CBM) Jumps: Stock Adds 13.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 8:46AM CST
Cambrex Corp. was a big mover last session, with shares rising over 13%.

Heska Corporation to Present at the Sidoti Semi-Annual Micro-Cap Conference
PR Newswire - Wed Jan 08, 8:00AM CST
Heska Corporation (NASDAQ:HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and other specialty veterinary products, today announced that Robert Grieve, chairman and chief executive officer, will present at the Sidoti & Company, LLC Semi-Annual New York Micro-Cap Conference at 10:40 a.m. ET on January 13, 2014 in the Estate 4/Carnegie Hall room at the Grand Hyatt New York Hotel. Heska management will be available during the day for one-on-one meetings. To schedule a meeting, please contact your Sidoti representative.

Peregrine Pharmaceuticals (PPHM) Soars: Stock Adds 14.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 7:57AM CST
Peregrine Pharmaceuticals, Inc. (PPHM) was a big mover last session, as the company saw its shares rise over 14% on the day.

MYGN Faces Payment Cuts, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 2:20PM CST
Shares of Myriad Genetics fell following the announcement by CMS to reduce reimbursement rates on the former's BRACAnalysis test.

Synta Pharmaceuticals Corp. (SNTA) Catches Eye: Stock Surges 11.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 7:44AM CST
Synta Pharmaceuticals Corp. was a big mover last session, as the company saw its shares rise nearly 12% on the day.

Synthetic Biologics (SYN) Jumps: Stock Up 5.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 03, 7:51AM CST
Synthetic Biologics Inc. was a big mover last session, as its shares rose over 5% on the day.

Immunomedics (IMMU) Jumps: Stock Adds 10.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 8:25AM CST
Immunomedics was a big mover last session, with shares rising over 10%.

Pluristem (PSTI) Jumps: Stock Adds 8.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 7:37AM CST
Pluristem Therapeutics, Inc. was a big mover last session, as the company saw its shares nearly 9% on the day.

Edwards Lifesciences Lifted to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 31, 5:26PM CST
On Dec 28, Zacks Investment Research upgraded medical device major, Edwards Lifesciences Corporation to a Zacks Rank #3 (Hold).

AVEO Pharmaceuticals, Inc. (AVEO) Catches Eye: Stock Rises 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 31, 7:44AM CST
AVEO Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise by 8% on the day.

Genomic Health Remains Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 27, 12:55PM CST
We reaffirm our long-term Neutral recommendation on Genomic Health following its third-quarter 2013 results.

Supernus Pharmaceuticals, Inc. (SUPN) Worth Watching: Stock Surges 13.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 26, 6:44AM CST
Supernus Pharmaceuticals, Inc was a big mover last session, as the company saw its shares rise over 13% on the day.

Synthetic Biologics (SYN) in Focus: Stock Surges 18.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 24, 7:25AM CST
Synthetic Biologics was a big mover last session, with shares rising over 18%.

Synergy Pharmaceuticals Catches Eyes: Stock Jumps 8.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 24, 6:44AM CST
Synergy Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise nearly 9% on the day

Myriad Maintained at Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 23, 3:45PM CST
On Dec 23, we reaffirmed our long-term Neutral recommendation on Myriad Genetics Inc.

Affymetrix Reaches New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 23, 1:00PM CST
Shares of Affymetrix started escalating following its promising third quarter results on Oct 30.

Jazz Pharmaceuticals plc (JAZZ) Catches Eye: Stock Rises 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 23, 6:44AM CST
Jazz Pharmaceuticals Public Limited Company was a big mover last session, as the company saw its shares gain 8% on the day.

Ariad Pharmaceuticals (ARIA) Worth Watching: Stock Surges 19.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 19, 6:44AM CST
Ariad Pharmaceuticals Inc. was a big mover last session, as the company saw its shares jump nearly 20% on the day.

Surging Rank, Surging Stock: Why InSite Vision (INSV) is a Winner? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 18, 6:30AM CST
One company that should be on your radar is InSite Vision Incorporated. The stock of this company has seen its Zacks Rank surge over the past four weeks, moving from Hold to its current position as a Strong Buy.

Heska Corp. (HSKA) Stock Research Links

HSKA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hi3D Unlocks AI 3D Model for Open-Source Innovation

Updated Category News Views 3

A New Era in 3D Model Accessibility Unless you’ve been hiding under a rock, it’s hard to miss how digital terraforming has shifted gears. With Hi3D V1.0 opening its doors, the playing field's getting a major reshuffle. Or, as they say, the table is being set, and everyone's getting a seat. By letting loose production-validated AI tools, Hi3D is throwing down the...

Continue Reading
Unicycive's Stock Plunge: Fraud Suit and FDA Hurdles

Updated Category News Views 7

Unicycive's Tumultuous Journey Lately, it's been a rocky road for Unicycive Therapeutics, Inc., with their stock free-falling 39.1% in the span of a heartbeat on June 30, 2026. What sparked this nosedive? The FDA kicked back their revised New Drug Application for a kidney disease treatment yet again, spotlighting old manufacturing issues never nipped in the bud. Talk...

Continue Reading
NYC's Carriage Horse Ban: A New Era for Urban Welfare

Updated Category News Views 4

You've got to hand it to New York City—this isn't just another Tuesday twist. The City Council's decision to nix horse-drawn carriages is like throwing a wrench in an antique machine. It's a bold move in a concrete jungle that's constantly wearing new coats. Tradition vs. Welfare: The Crux For years, the idea of horses prancing down NYC streets seemed like a quaint nod...

Continue Reading
Basic Invite's Holiday Card Service Offers Saving Time

Updated Category News Views 1

Getting the Cards Out: Maneuvering the Holiday Hustle Alright, let's dive into the madness that is holiday card season. Could be a logistical nightmare or a nostalgic tradition, depending on your cup of tea. Basic Invite here is trying to cut through the chaos by bumping deadlines and offering some straight-out-the-gate mailing options. If you play your cards right—pun...

Continue Reading
D-Wave Investors Face Pressure Ahead of December 15

Updated Category News Views 3

Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...

Continue Reading
Celebrating Alexander Trost: A Lifetime of Compassionate Care

Updated Category News Views 4

A Legendary Career in Palliative Medicine You know, in a world where people glamorize stock flips and flashy earnings, it's refreshing to spotlight good old-fashioned compassion. Enter Dr. Alexander Trost, DNP, FNP-C, ACHPN. This fella has just been honored as a Pinnacle Lifetime Member by The Inner Circle—a nod to his impactful work in palliative medicine. You ever try...

Continue Reading
Tigo Energy Faces Class Action Over Revenue Claims

Updated Category News Views 3

Trouble Brewing for Tigo Energy? Straight from the horse's mouth, we hear about Tigo Energy (NASDAQ: TYGO) getting embroiled in a class action smackdown. Picture it: Tigo fumbles their projections, and boy does it sting. They're caught in the crossfire for allegedly puffing up their revenue expectations tied to a venture with EG4 Electronics—poised to churn out...

Continue Reading
Rising Food Safety Stars Honored: A Global Effort

Updated Category News Views 2

Food Safety Breakthrough: Youth Leads the Charge When it comes to food safety, it’s about time the younger crowd gets their due. The latest crew to step up to the plate is the Class of 2026's 40 Under 40 Food Safety Professionals. They’re not just pushing paper; these folks are setting the bar high and innovating across continents with real, tangible changes. From...

Continue Reading
Ellington's Q3 Earnings Call: What Investors Need to Know

Updated Category News Views 5

An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...

Continue Reading
Dott's Q3 2026: Micromobility Growth Soars High

Updated Category News Views 5

Riding the Wave of Profit in Micromobility Sometimes all you need is a quick jolt of genius to turn the wheels of fortune. Dott seems to have hit that sweet spot in Q3 of 2026. Deploying 45,000 new vehicles wasn’t just a logistical feat; it was a calculated bet that paid off handsomely, bolstering their business to soaring heights. Performance that Packs a Punch The Q3...

Continue Reading

Top 5 Most Recently Viewed Articles

ComFree's Remarkable Comeback: A New Era in Real Estate

Updated Category News Views 375

ComFree's Return to the Market After a notable absence, ComFree is back, igniting excitement in the real estate industry. The company's founders, Erin and Travis Holowach, originally created ComFree as a platform for homeowners to sell properties without agent interference, saving them significant fees. Their mission is now revitalized as they reclaim the brand they built...

Continue Reading
Why Capital Gains Tax Planning Matters for Long-Term Investors

Updated Category Investing Views 159

The average federal income tax paid by a typical person ranges from 13.5% to 15%, and tax planning is a mathematical necessity for anyone serious about building long-term wealth in the United States. Every dollar lost to an inefficient exit from an investment is a dollar that stops compounding for your future self. There are thousands of taxable events triggered daily...

Continue Reading
Biomea Fusion Reports Milestone 52-Week Findings in Diabetes

Updated Category News Views 164

Biomea Fusion Unveils Promising Efficacy of Icovamenib Biomea Fusion, Inc. (Nasdaq: BMEA), a pioneer in clinical-stage advancements for diabetes and obesity, recently announced significant 52-week results from its Phase II COVALENT-111 study. This study examined the potential effects of icovamenib, a novel treatment for type 2 diabetes (T2D), and the results underscore a...

Continue Reading
D-Wave Hit with Legal Scrutiny After Disappointing Q2

Updated Category News Views 23

D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...

Continue Reading
Groundbreaking Debut of DeriW Exchange at Exclusive Event

Updated Category News Views 309

Groundbreaking Launch of DeriW Exchange DeriW, an innovative decentralized perpetual exchange, has officially launched during an exclusive event, showcasing its advanced features and capabilities. The event, hosted by CoinW, attracted 400 influential figures from the cryptocurrency sector. Among the attendees were thought leaders, blockchain pioneers, and affiliates, all...

Continue Reading